SpringWorks Therapeutics Inc. (SWTX) Cash Flow Statement

Click line-items for a historical chart and %

Net income	976K
Gain on acquisition of controlling interest in SIG	0
Deferred income tax	-10K
Loss on disposal of property, plant and equipment	39K
Depreciation and amortization	2.57M
Goodwill and intangible assets impairment	1.83M
Stock-based compensation	740K
(Provision for) inventory reserves	-130K
Recovery of returns and allowance resesrve	188K
Non-cash effect of acquisition of controlling interest in SIG	0
Accounts receivable, net	-2.02M
Inventories, net	-2.5M
Other current and non-current assets	-191K
Accounts payable and accrued liabilities	525K
Net cash provided by operating activities	2.02M
Acquisition of controlling interest in SIG, net of cash acquired	0
Expenditures for property, plant and equipment	-2.24M
Net cash used in investing activities	-2.24M
Proceeds from stock option exercises	71K
Repayments of term debt and capital lease obligations	-696K
Proceeds from investment credit	11K
Net cash used in financing activities	-614K
Effect of foreign exchange rate changes on cash and cash equivalents	-77K
Net increase (decrease) in cash and cash equivalents	-914K
Cash and cash equivalents, beginning of period	13.78M
Cash and cash equivalents, end of period	12.86M
Interest paid	181K
Income taxes paid	765K
Dividends accrued
Deposits applied to acquisition of property, plant and equipment	86K
Acquisition of interest in SIG (Note 12)	246K

Entities mentioned with SWTX

View All Entities